Personal protective equipment and antiviral drug use during hospitalization for suspected avian or pandemic influenza

Emerg Infect Dis. 2007 Oct;13(10):1541-7. doi: 10.3201/eid1310.070033.

Abstract

For pandemic influenza planning, realistic estimates of personal protective equipment (PPE) and antiviral medication required for hospital healthcare workers (HCWs) are vital. In this simulation study, a patient with suspected avian or pandemic influenza (API) sought treatment at 9 Australian hospital emergency departments where patient-staff interactions during the first 6 hours of hospitalization were observed. Based on World Health Organization definitions and guidelines, the mean number of "close contacts" of the API patient was 12.3 (range 6-17; 85% HCWs); mean "exposures" were 19.3 (range 15-26). Overall, 20-25 PPE sets were required per patient, with variable HCW compliance for wearing these items (93% N95 masks, 77% gowns, 83% gloves, and 73% eye protection). Up to 41% of HCW close contacts would have qualified for postexposure antiviral prophylaxis. These data indicate that many current national stockpiles of PPE and antiviral medication are likely inadequate for a pandemic.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use
  • Australia
  • Guideline Adherence
  • Humans
  • Infection Control / methods*
  • Infection Control / standards*
  • Infectious Disease Transmission, Patient-to-Professional / prevention & control*
  • Influenza A Virus, H5N1 Subtype*
  • Influenza, Human / drug therapy
  • Influenza, Human / prevention & control*
  • Patient Simulation
  • Personnel, Hospital
  • Prospective Studies
  • Protective Clothing / statistics & numerical data
  • Quality Assurance, Health Care

Substances

  • Antiviral Agents